ALX Oncology Holdings Inc (ALXO) options traded 458 contracts on Nov 4, 2026, well above the 20-day average of 281. Calls made up 100.0% of the volume, a put/call ratio of 0.00.
Option Volume by Strike
Showing results for ALXO, 2026-11-20(m), calls & puts
Option Volume Stats
Showing results for ALXO, 2026-11-20(m), calls & puts
| Call Volume | |
|---|---|
| Put Volume | |
| Volume Total | |
| Put-Call Volume Ratio |
Highest Volume Options
Showing results for ALXO, 2026-11-20(m), calls & puts
Option Volume Total by Expiry
Showing results for ALXO, 2026-11-20(m), calls & puts. View all expiries
Option Volume History
Showing daily totals for ALXO, all expirations, calls & puts. View full history
ALXO Option Volume FAQ
What is option volume?
Option volume is the number of option contracts traded during a session. It resets at the start of each trading day.
How many ALXO options traded on Nov 4, 2026?
458 calls and 0 puts traded on Nov 4, 2026, 458 contracts in total.
Is ALXO option volume higher than usual?
Volume on Nov 4, 2026 was well above the 20-day average of 281 contracts. The busiest of the last 20 sessions was Oct 16, 2026, with 1.5K contracts. The 30-day average is 266. See the ALXO option volume history for a longer view.
What is the ALXO put/call volume ratio?
The ALX Oncology put/call volume ratio was 0.00 on Nov 4, 2026. Over the last 20 sessions it averaged 0.64, so calls outnumber puts over that stretch.
What is ALX Oncology Holdings Inc?
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials.